Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In a phase 2 clinical trial targeting obese individuals without type 2 diabetes (T2D), retatrutide dosed at 1 to 12 mg resulted in up to 24.2% weight loss over a 48-week treatment period, compared to 2.1% in the placebo group, and demonstrated a dose-dependent effect
Discontinuing Glucagon-Like Peptide-1 Receptor Agonists and Body Habitus: A Systematic Review and Meta-Analysis
PMID: 23658898
Knowing the risks can help you make better decisions
Deficiency in B12 can lead to a wide array of symptoms, including fatigue, memory loss, weakness, and neurological disturbances
US$ 24.83
US$ 27.24
US$ 29.94
US$ 24.75
US$ 25.69
